The world’s No. 2 cigarette maker is currently awaiting approval from the U.S. Food and Drug Administration to proceed with Phase 1 trials. Read More
Tags :British American Tobacco
Scientists at British American Tobacco (BAT) have proposed a new scientific framework that could be used to assess the reduced-risk potential of nicotine and tobacco products currently being developed. The new assessment framework employs a Read More
